4-Methyl-6,8-dioxabicyclo[3.2.1]octane-2,3-diol

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 氧杂环己烷
• 英文名称: 4-Methyl-6,8-dioxabicyclo[3.2.1]octane-2,3-diol
• 英文别名: 4-methyl-6,8-dioxabicyclo[3.2.1]octane-2,3-diol
• 化学式: C₇H₁₂O₄
• 分子量: 160.17
• InChiKey: QRSZLMMIKOAPHK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.7
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  58.9
• 氢给体数：
  2
• 氢受体数：
  4

文献信息

• AN EFFICIENT AND SCALABLE PROCESS FOR THE MANUFACTURE OF FONDAPARINUX SODIUM
  申请人：Reliable Biopharmaceutical Corporation

  公开号：EP2809678B1

  公开（公告）日：2017-03-22
• IMMOBILISED BIOLOGICAL ENTITIES
  申请人：CARMEDA AB

  公开号：US20210379253A1

  公开（公告）日：2021-12-09

  There is provided inter alia an anticoagulant surface which surface has covalently bound thereto a plurality of fragments of heparin, wherein said fragments consist of 5-18 saccharide units and at least some of said plurality of fragments comprise polysaccharide sequence A, which surface catalyses the inhibition of FIIa and FXa by AT.
• [EN] IMMOBILISED BIOLOGICAL ENTITIES<br/>[FR] ENTITÉS BIOLOGIQUES IMMOBILISÉES
  申请人：CARMEDA AB

  公开号：WO2020070258A1

  公开（公告）日：2020-04-09

  There is provided inter alia an anticoagulant surface which surface has covalently bound thereto a plurality of fragments of heparin, wherein said fragments consist of 5-18 saccharide units and at least some of said plurality of fragments comprise polysaccharide sequence A, which surface catalyses the inhibition of FIIa and FXa by AT.